Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-02

Clinical Trial Update: The Effect of A-lipoic Acid (ALA) on Fatty Acid-induced Impairment of Glucose-stimulated Insulin Secretion [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effect of alpha-lipoic acid on fatty acid-induced impairment of glucose-stimulated insulin secretion in people with Type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 2 Diabetes, Prediabetes | Phase 4 | Status: COMPLETED